Enrolling Now

Enrolling Now

See if you qualify

Automated Insulin Delivery

Type 1 Diabetes (ages 7 to 85) and insulin-requiring Type 2 Diabetes (18 to 85)

Locations: Long Island City, Queens (36-36 33rd Street)

Cost to you: none for study visits, tests, or study medication

Questions: 516-574-9232 · Hablamos español

  • A study evaluating an automated insulin delivery (AID) system in children and adults living with diabetes.

    • Type 1 diabetes: ages 7 to 85, diagnosed at least 6 months ago

    • Type 2 diabetes: ages 18 to 85, insulin-requiring for at least 1 year

    • Willing to wear the system continuously throughout the study

    • HbA1c of 11.0% or less at screening

    • Willing to use, and able to cover the cost of, one of the study insulins: Humalog, NovoLog/NovoRapid, Admelog, Merilog, or authorized generic insulin aspart or lispro

  • Gain access to cutting-edge medications and treatments before they are widely available.

    Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.

    We are highly focused on patient well-being and the highest ethical standards in clinical research.

A yellow background with a coiled white measuring tape, some white pills scattered near the tape.